Ryan Gilbert
Family · Philadelphia, PANPI 1255002549
Payments from drug & device makers
Across 233 payments — averaging $21.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Lilly USA, LLC$744
- AstraZeneca$441
- Novo Nordisk$417
- GSK$371
- Astellas Pharma US Inc$259
- plus $2K from 19 others
What the payments were for
- Food & beverage$4,93398%
- Education$992%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 61 | $1,179 |
| Lilly USA, LLC | 35 | $744 |
| AstraZeneca | 15 | $441 |
| Novo Nordisk | 21 | $417 |
| GSK | 16 | $371 |
| Astellas Pharma US Inc | 9 | $259 |
| Amgen(2 entities) | 11 | $255 |
| Exact Sciences | 9 | $205 |
| Xeris Pharmaceuticals, Inc. | 7 | $155 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $153 |
| Boehringer Ingelheim | 6 | $115 |
| Pfizer | 5 | $104 |
| Paratek Pharmaceuticals, Inc. | 5 | $101 |
| Novartis | 5 | $99 |
| Viatris Specialty LLC | 4 | $94 |
| Bayer | 3 | $60 |
| Shield Therapeutics Inc | 1 | $56 |
| Mylan Specialty L.p. | 3 | $44 |
| Hologic Sales And Service, LLC | 2 | $43 |
| Currax Pharmaceuticals LLC | 2 | $32 |
| BETA Bionics, Inc. | 1 | $26 |
| Johnson & Johnson | 1 | $23 |
| Inspire Medical Systems, Inc. | 1 | $21 |
| Merck | 1 | $20 |
| Almatica Pharma LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,032 in reported general payments places this provider in the 90th percentile of 4,717 family providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 35 | $36,451 |
| JardianceEmpagliflozin | 58 | $34,062 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 23 | $22,908 |
| XareltoRivaroxaban | 26 | $16,563 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 18 | $11,185 |
| EliquisApixaban | 16 | $9,201 |
| MyrbetriqMirabegron | 16 | $7,042 |
| Diclofenac Potassium | 27 | $6,356 |
| SymbicortBudesonide/Formoterol Fumarate | 18 | $4,159 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 19 | $3,160 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 20 | $2,931 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 20 | $2,361 |
| Lidocaine | 15 | $1,769 |
| Rosuvastatin Calcium | 94 | $1,479 |
| Bupropion XlBupropion Hcl | 42 | $1,273 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity | $744 | $36,45135 claims |
| Boehringer IngelheimJardiance | $115 | $34,06258 claims |
| GSKTrelegy Ellipta | $371 | $22,90823 claims |
| Johnson & JohnsonXarelto | $23 | $16,56326 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $441 | $15,34436 claims |
| PfizerEliquis | $104 | $9,20116 claims |
| Astellas Pharma US IncMyrbetriq | $259 | $7,04216 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,717 family providers in Pennsylvania.
Other family in Philadelphia
- Bethany ThomasPhiladelphia$126K
- Anne CalvaresiPhiladelphia$81K
- Bethany MooneyPhiladelphia$73K
- Susan Estrella-EadesPhiladelphia$61K
- Michelle Vega-OlivoPhiladelphia$55K
- Danielle LandPhiladelphia$48K
- Nicole SmithPhiladelphia$37K
- Dana SerafinPhiladelphia$31K
- Tammaris KaschakPhiladelphia$27K
- Laura NoltePhiladelphia$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.